MedPath

Neuropsychological Indicators of SCD Progression

Completed
Conditions
Neurodegenerative Diseases
Subjective Cognitive Decline
Cognitive Assessment
Biomarkers
Neurocognitive Disorders
Cognitive Decline
Registration Number
NCT04880252
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have not been identified. The investigators objective was to examine baseline neuropsychological indicators that could discriminate between people in whom the SCD progressed to a mild or major NCD and people in whom the SCD remained stable.

The investigators retrospectively included patients consulting for SCD at a university medical center's memory center (Amiens, France) and who had undergone three or more neuropsychological assessments at least 6 months apart. The relationship between domain-specific scores and the global cognitive score (GCS, as a function of final status (stable SCD vs. progression toward a mild or major NCD)) was examined using a generalized linear mixed model.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • patients who had been referred to the memory center at Amiens University Medical Center (Amiens, France).
  • patients who had undergone three neuropsychological assessments at least 6 months apart, from 2005
  • patients who met the criteria for SCD.
Exclusion Criteria
  • patients who didn't meet the criteria for SCD

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Variation of neuropsychological indicators (global congnitive score) between NCD et SCD patientsone year

subjective cognitive decline (SCD) neurocognitive disorders (NCD) neuropsychological indicators could discriminate between people in whom SCD progressed to a mild or major NCD and people in whom SCD remained stable.

A global cognitive score was created using all 5 tests : Alice Heim 4-I tests inductive reasoning ; Short-term verbal memory was assessed with a 20-word free-recall test; Two measures of verbal fluency were used: phonemic and semantic; Vocabulary was assessed using the Mill Hill Vocabulary test.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath